Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01253759 · ClinicalTrials.gov registry record
Long Term Results of Combined Transpupillary Thermotherapy (TTT) Indocyanine Green (ICG) Based Photodynamic Therapy (PDT) in Choroidal Melanoma
A clinical trial, sponsored by New England Retina Associates.
- Completed
- Registry status
- 46
- Enrollment target
NCT01253759 is a clinical trial that has completed, run by New England Retina Associates. The registered enrollment target is 46 participants.
The verdict
NCT01253759 has completed, sponsored by New England Retina Associates.
- COMPLETED
- Registry status
- 46 participants
- Enrollment target
Study Summary
This is a report of 10 years results of combined Transpupillary thermotherapy (TTT) treatment with Indocyanine green (ICG) in controlling small and medium-sized choroidal melanomas.
Interventions
- PROCEDURE TTT + ICG-based PDT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2009-01 |
| Est. Completion | 2009-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01253759
The ClinicalTrials.gov registry entry for NCT01253759 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New England Retina Associates, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TTT + ICG-based PDT is the first listed.
NCT01253759 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01253759 about?
NCT01253759 is a clinical study titled "Long Term Results of Combined Transpupillary Thermotherapy (TTT) Indocyanine Green (ICG) Based Photodynamic Therapy (PDT) in Choroidal Melanoma". This is a report of 10 years results of combined Transpupillary thermotherapy (TTT) treatment with Indocyanine green (ICG) in controlling small and medium-sized choroidal melanomas.
What is the current status of trial NCT01253759?
This trial is currently completed. The enrollment target is 46 participants. The study started on 2009-01. Estimated completion is 2009-03.
What interventions are being tested in trial NCT01253759?
The interventions under investigation include: TTT + ICG-based PDT (PROCEDURE).
Who is sponsoring clinical trial NCT01253759?
This trial is sponsored by New England Retina Associates, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.